Presbyopia Drops, a Promising Solution - Takeaways - MDSpire
Advertisement
Presbyopia Drops, a Promising Solution
While over-the-counter, prescription corrective lenses, and surgical interventions have been the mainstays of presbyopia management, presbyopia drops offer a non-invasive alternative.
Presbyopia drops, such as Vuity and Qlosi, offer a non-invasive alternative for managing near vision in patients over 40.
2
Clinical trials demonstrated that presbyopia drops significantly improve near vision while preserving distance vision, even in low-light conditions.
3
Careful patient selection and education are crucial for optimal outcomes, particularly for motivated individuals aged 40 to 50 with early to moderate presbyopia.
4
The FDA approved a twice-daily dosing option for Vuity in 2023, extending its effectiveness from 6 to 9 hours.
5
Common side effects of presbyopia drops include headaches and eye irritation, emphasizing the importance of patient counseling and adherence.
